drugset / Trial / NCT05297422
Axillary Approach to Brachial Plexus Blockade Using Ketamine, Regional Versus Intravenous Administration
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to assess Ketamine as an adjuvant to Branchial Plexus Blockade.
Timeline
- Start
- 2022-01-20
- Primary completion
- 2023-05
- Completion
- 2023-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketamine | Small molecule | 30 mg | Intravenous |
| Comparator | Ropivacaine | Other / unclassified | 0.5 % | — |
| Comparator | Ropivacaine | Other / unclassified | 30 ml | — |